SecProbe.io

CORRESP
1
filename1.htm

MEDICAL
TRANSCRIPTION BILLING, CORP.

7
Clyde Road

Somerset,
New Jersey 08873

July
12, 2017

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
DC 20549

    Attn:

    Ms.
    Jan Woo

    Ms.
    Ji Shin

    Re:
    Medical
    Transcription Billing, Corp.

    Amendment
    No. 1 to Registration Statement on Form S-1

    Submitted
    July 7, 2017

    File
    No.: 333-219122

Ladies
and Gentlemen:

Medical
Transcription Billing, Corp., a Delaware corporation (the “Company”), hereby undertakes to promptly file a post-effective
amendment to its Registration Statement on Form S-1 (File No. 333-214863) to deregister all of the shares registered thereunder
that were not sold by the Company it is recently completed offering of its Series A Preferred Stock.

Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the Company hereby requests that the effective
date for the above captioned Registration Statement (File No.: 333-219122) be accelerated so that it will be declared effective
on July 13, 2017 at 4:00 p.m., Eastern time, or as soon thereafter as practicable. In making this acceleration request, the Company
acknowledges that it is aware of its responsibilities under the Act.

The
Company requests that it be notified of such effectiveness by a telephone call to Mr. David Song, of Mazzeo Song P.C., at (212)
599-3077, or, in his absence, to Ms. Shruti Patel, the Company’s general counsel, at (732) 873-5133 x146.

    Sincerely,

    MEDICAL TRANSCRIPTION BILLING, CORP.

    By:
    /s/
    Mahmud Haq

    Mahmud
    Haq, Chairman and CEO

    cc:
    Mr.
    Stephen Snyder, Medical Transcription Billing, Corp.

    Mr.
    Bill Korn, Medical Transcription Billing, Corp.

    Ms.
    Shruti Patel, Medical Transcription Billing, Corp.

    David
    Song, Mazzeo Song P.C.